PaxlovidTM – Making an Informed Decision

Canadian Covid Care Alliance

In January 2022, Health Canada approved the use of the oral antiviral medication called PAXLOVIDTM. PAXLOVIDTM is made of a combination of two medications: nirmatrelvir and ritonavir.

As with any medication, there are a number of key questions that healthcare practitioners can and do use to help determine if it is a good choice for their patients. We felt it important to offer the public the same kind of review, especially since this is a new medication.

You might also be interested in

Latest articles

Tracy Vaillancourt et al. Children and youth flourish in environments that are...
Eric Hussey … Visual neurology – all neurology – requires the correct...
Robert Freudenthal “My mask protects you, your mask protects me” is the...
Paul Elias Alexander It is not unreasonable to conclude that surgical and...
Canadian Covid Care Alliance 6 Health-promoting foods, herbs, and spices that naturally...
Vitality Magazine Canadians injured by COVID-19 vaccines were among those who reported...

Your donation helps us
stand up for health freedom!

Canada Health Alliance is volunteer run and 100% supported by the generous donations of those who share our concerns and value our work.

Stay up to date

Sign up to our newsletter to get the latest health-related news and events delivered straight to your inbox.

Become a CHA member

Become an active value-added member and trusted provider of medical and healthcare information and education by joining the CHA Membership Program.

Your donation helps us stand up for healthcare choice!

Canada Health Alliance is volunteer run and 100% supported by the generous donations of those who share our concerns and value our work.

Thank you!

The form has been submitted successfully!